Celldex Therapeutics, Inc. (CLDX)
Data as of , from SEC Form 4 filings.
See up to 3 months of CLDX. The 7-day demo opens the 1M and 3M ranges and puts CLDX on your watchlist.
Start 7-day demoLatest CLDX insider trades
About Celldex Therapeutics, Inc. (CLDX)
The SEC lists Celldex Therapeutics, Inc. under CIK 0000744218, in in vitro and in vivo diagnostic substances. It is grouped with Health Care companies on this site.
CLDX Form 4 activity by transaction type, last 90 days
No Form 4 activity for CLDX in the last 90 days.
CLDX insider transactions (Form 4)
3427 Form 4 filings on record, the earliest from Nov 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Teri L. Lawver - Officer | Grant or award | Incentive Stock Option (right to buy) | 90,000 | $0.00 | - | |
| Freddy A. Jimenez - Officer | Grant or award | Incentive Stock Option (right to buy) | 93,000 | $0.00 | - | |
 Diane C. Young - Officer | Grant or award | Incentive Stock Option (right to buy) | 57,000 | $0.00 | - | |
| Margo Heath-Chiozzi - Officer | Grant or award | Incentive Stock Option (right to buy) | 95,000 | $0.00 | - | |
| Samuel Bates Martin - Officer | Grant or award | Incentive Stock Option (right to buy) | 93,000 | $0.00 | - | |
 Sarah Cavanaugh - Officer | Grant or award | Incentive Stock Option (right to buy) | 95,000 | $0.00 | - | |
 Elizabeth Crowley - Officer | Grant or award | Incentive Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Ronald Pepin - Officer | Grant or award | Incentive Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Tibor Keler - Officer | Grant or award | Incentive Stock Option (right to buy) | 115,000 | $0.00 | - | |
| Anthony S. Marucci - Officer | Grant or award | Incentive Stock Option (right to buy) | 375,000 | $0.00 | - | |
| Denice Torres | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
 Rita Jain | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| Garry Arthur Neil | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
 Cheryl Cohen | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| Keith L. Brownlie | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| James J. Marino | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| Herbert J. Conrad | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| Harry Penner Jr. | Grant or award | Non-Qualified Stock Option (right to buy) | 26,000 | $0.00 | - | |
| Richard M. Wright | Option exercise | Incentive Stock Option | 6,876 | $0.00 | - | |
| Richard M. Wright | Option exercise | Incentive Stock Option | 26,672 | $0.00 | - | |
| Richard M. Wright | Option exercise | Incentive Stock Option | 15,750 | $0.00 | - | |
| Richard M. Wright | Option exercise | Common Stock | 6,876 | $9.02 | $62K | |
| Richard M. Wright | Option exercise | Common Stock | 26,672 | $10.38 | $277K | |
| Richard M. Wright | Option exercise | Common Stock | 15,750 | $22.48 | $354K | |
| Richard M. Wright | Open-market sale | Common Stock | 49,298 | $24.00 footnote F1 | $1.18M | |
| ||||||
| Teri L. Lawver - Officer | Grant or award | ISO (right to buy) | 100,000 | $0.00 | - | |
| Freddy A. Jimenez - Officer | Open-market sale | Common Stock | 341 | $23.95 | $8K | |
| Freddy A. Jimenez - Officer | Open-market sale | Common Stock | 430 | $25.42 | $11K | |
| Herbert J. Conrad | Grant or award | Non-Qualified Stock Option (right to buy) | 16,500 | $0.00 | - | |
| Ronald Pepin - Officer | Grant or award | Incentive Stock Option (right to buy) | 20,000 | $0.00 | - | |
| James J. Marino | Grant or award | Non-Qualified Stock Option (right to buy) | 16,500 | $0.00 | - | |
| Harry Penner Jr. | Grant or award | Non-Qualified Stock Option (right to buy) | 16,500 | $0.00 | - | |
| James J. Marino | Gift | Common Stock | 10,500 | $0.00 | - | |
| Anthony S. Marucci - Officer | Open-market purchase | Common Stock | 11,500 | $26.82 | $308K | |
CLDX insider trading FAQ
What is the latest insider trade for CLDX?
Celldex Therapeutics, Inc. (CLDX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-29. The full record for CLDX runs to 27 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CLDX stock?
No insider purchases of CLDX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling CLDX stock?
No insider sales of CLDX were filed in the last 90 days. 3 sales are on record for this company.
Where can I see CLDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CLDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Teri L. Lawver view on EDGAR
- - Freddy A. Jimenez view on EDGAR
- - Diane C. Young view on EDGAR
- - Margo Heath-Chiozzi view on EDGAR
- - Samuel Bates Martin view on EDGAR
- - Sarah Cavanaugh view on EDGAR
- - Elizabeth Crowley view on EDGAR
- - Ronald Pepin view on EDGAR
- - Tibor Keler view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CLDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CLDX with a 7-day demo
- CLDX on your watchlist
- Every CLDX Form 4 filing on record
- Up to 3 months of CLDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
